Illumina Inc

ILMN · Moat type: UNBESTIMMT

MoatScore

5/10

Fair Value

111 USD

Margin of Safety

-70.9 %

Rating

BEOBACHTEN

Illumina develops and markets sequencing systems (instruments, reagents, software) for genomics research and clinical diagnostics, and generates the majority of its revenues from recurring consumables business tied to the installed instrument base.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.